ARCHIVES

Pryor Bill Embodies Drug Company Fears

This article is from The Cancer Letter archive.

Vol. 20 No. 27 | July 8, 1994

Download PDF Visit The Full Archive

Related Articles

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Combination Therapy Improves Survival For HIV+ Patients

February 24, 2006

NCI Offers Coded Serum Panels

May 28, 1982

Nine Saturation Program Planning Contracts Approved

May 9, 1975

In Brief: 163 PIs Hold Both Contracts, Grants; Hopkins Scientists Questions Retrospective Diet Studies

August 27, 1976

Institute Of Medicine Report Says Insurers Should Pay Patient Care Costs In Clinical Trials

February 24, 1989